News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Synta Pharmaceuticals to Host First-Quarter 2012 Conference Call on May 3, 2012
April 19, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its first-quarter 2012 financial results before the market opens on Thursday, May 3, 2012.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac
China
Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
September 29, 2026
·
2 min read
·
Annalee Armstrong
Eye disease
Kodiak Sciences’ stock soars 166% after 2 assets match Eylea in Phase 3 trial
September 28, 2026
·
1 min read
·
Gabrielle Masson
Licensing
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
September 28, 2026
·
2 min read
·
Gabrielle Masson
